University of California Davis Health
Sacramento, California, 95817, United States
NCT Number: NCT05675995
The purpose of this study is to conduct a pilot feasibility study of a combination of external and internal qigong on health-related quality of life in individuals with prolonged symptoms following COVID-19 infection.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Sacramento, California, 95817, United States
The purpose of this study is to determine whether a combination of external and internal qigong, a traditional Chinese medicine healing practice, improves quality of life and symptoms for individuals with prolonged symptoms following a COVID-19 infection (sometimes called "long COVID"). The study involves completing questionnaires and participating in 6 weekly in person small group qigong sessions with an experienced qigong practitioner.
Participants will be randomized to participate in either an immediate or waitlist control group that will receive the qigong sessions starting 8 weeks later. Participants will complete 3 sets of questionnaires, each about 8 weeks apart and an interview about their experiences with qigong after completing the 6 sessions.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
6 sessions of combined external and internal qigong delivered in a group-based format once a week.
Time frame: 8 weeks
Changes in PROMIS-29 summary scores from before to after intervention in all participants
University of California, Davis
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06305793
COVID-19, Chronic Disease
Durham, North Carolina, United States
View Trial DetailsNCT07005921
Behavior, Behavioral Symptoms
Macaíba, Rio Grande do Norte, Brazil
View Trial DetailsNCT05758480
COVID-19, Chronic Disease
Angers, France
View Trial DetailsNCT06404112
COVID-19, Chronic Disease
Durham, North Carolina, United States
View Trial Details